Following on from lilypily's comments, the other FDA division wanted toxicology results and to see the Rett 2b results.
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren completes Phase 2 trial in pediatric Rett syndrome
NEU
neuren pharmaceuticals limited
Add to My Watchlist
10.1%
!
$13.80

Ann: Neuren completes Phase 2 trial in pediatric Rett syndrome, page-30
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.80 |
Change
1.260(10.1%) |
Mkt cap ! $1.729B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $12.72M | 926.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 459 | $13.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.80 | 102 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 253 | 13.820 |
3 | 716 | 13.810 |
2 | 416 | 13.800 |
5 | 1309 | 13.790 |
4 | 1316 | 13.780 |
Price($) | Vol. | No. |
---|---|---|
13.830 | 1 | 1 |
13.840 | 788 | 10 |
13.850 | 1423 | 4 |
13.860 | 1392 | 6 |
13.870 | 1291 | 4 |
Last trade - 14.26pm 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online